Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus

Introduction. One of the serious complications after transplantation of solid organs and bone marrow is the development of post-transplant lymphoproliferative diseases.Clinical case. To evaluate the course of post-transplant lymphoproliferative diseases in the long-term in a liver transplant recipie...

Full description

Saved in:
Bibliographic Details
Main Authors: V. E. Syutkin, V. R. Gorodetskiy, A. A. Salienko, N. A. Probatova, N. A. Kupryshina, M. S. Novruzbekov
Format: Article
Language:English
Published: N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2021-09-01
Series:Трансплантология (Москва)
Subjects:
Online Access:https://www.jtransplantologiya.ru/jour/article/view/587
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850041548558827520
author V. E. Syutkin
V. R. Gorodetskiy
A. A. Salienko
N. A. Probatova
N. A. Kupryshina
M. S. Novruzbekov
author_facet V. E. Syutkin
V. R. Gorodetskiy
A. A. Salienko
N. A. Probatova
N. A. Kupryshina
M. S. Novruzbekov
author_sort V. E. Syutkin
collection DOAJ
description Introduction. One of the serious complications after transplantation of solid organs and bone marrow is the development of post-transplant lymphoproliferative diseases.Clinical case. To evaluate the course of post-transplant lymphoproliferative diseases in the long-term in a liver transplant recipient after conversion of immunosuppressive therapy from tacrolimus to everolimus. We analyze a case of generalized primary plasmacytoma of lymph nodes with bone marrow involvement in a patient after liver transplantation.Results. After conversion of immunosuppression we observed a rapid positive trend: decreasing size of lymph nodes and regression of the level of paraprotein down to its complete disappearance. There were neither adverse events associated with everolimus for four years, nor signs of immunosuppression insufficiency.Conclusion. This Case Report is the first description of a long-term remission of nodal plasmacytoma that developed in a liver transplant recipient after complete withdrawal of calcineurin inhibitors and administration of everolimus. We suggest that the regression of post-transplant lymphoproliferative diseases after replacing calcineurin inhibitors with everolimus is associated not only with the minimization of calcineurin inhibitors exposure, but also with the antitumor effect of the everolimus itself, which prompts us to discuss the possibilities of expanding its clinical application.
format Article
id doaj-art-e82423111c574422bf36ab46298ca549
institution DOAJ
issn 2074-0506
2542-0909
language English
publishDate 2021-09-01
publisher N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department
record_format Article
series Трансплантология (Москва)
spelling doaj-art-e82423111c574422bf36ab46298ca5492025-08-20T02:55:45ZengN.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare DepartmentТрансплантология (Москва)2074-05062542-09092021-09-0113327227910.23873/2074-0506-2021-13-3-272-279488Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimusV. E. Syutkin0V. R. Gorodetskiy1A. A. Salienko2N. A. Probatova3N. A. Kupryshina4M. S. Novruzbekov5N.V. Sklifosovsky Research Institute for Emergency MedicineResearch Institute of Rheumatology n.a. V.A. NasonovaN.V. Sklifosovsky Research Institute for Emergency MedicineN.N. Blokhin National Medical Research Center of OncologyN.N. Blokhin National Medical Research Center of OncologyN.V. Sklifosovsky Research Institute for Emergency MedicineIntroduction. One of the serious complications after transplantation of solid organs and bone marrow is the development of post-transplant lymphoproliferative diseases.Clinical case. To evaluate the course of post-transplant lymphoproliferative diseases in the long-term in a liver transplant recipient after conversion of immunosuppressive therapy from tacrolimus to everolimus. We analyze a case of generalized primary plasmacytoma of lymph nodes with bone marrow involvement in a patient after liver transplantation.Results. After conversion of immunosuppression we observed a rapid positive trend: decreasing size of lymph nodes and regression of the level of paraprotein down to its complete disappearance. There were neither adverse events associated with everolimus for four years, nor signs of immunosuppression insufficiency.Conclusion. This Case Report is the first description of a long-term remission of nodal plasmacytoma that developed in a liver transplant recipient after complete withdrawal of calcineurin inhibitors and administration of everolimus. We suggest that the regression of post-transplant lymphoproliferative diseases after replacing calcineurin inhibitors with everolimus is associated not only with the minimization of calcineurin inhibitors exposure, but also with the antitumor effect of the everolimus itself, which prompts us to discuss the possibilities of expanding its clinical application.https://www.jtransplantologiya.ru/jour/article/view/587liver transplantationpost-transplant lymphoproliferative diseasesproliferation signal inhibitorseverolimus
spellingShingle V. E. Syutkin
V. R. Gorodetskiy
A. A. Salienko
N. A. Probatova
N. A. Kupryshina
M. S. Novruzbekov
Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
Трансплантология (Москва)
liver transplantation
post-transplant lymphoproliferative diseases
proliferation signal inhibitors
everolimus
title Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
title_full Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
title_fullStr Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
title_full_unstemmed Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
title_short Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
title_sort complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
topic liver transplantation
post-transplant lymphoproliferative diseases
proliferation signal inhibitors
everolimus
url https://www.jtransplantologiya.ru/jour/article/view/587
work_keys_str_mv AT vesyutkin completeregressionofgeneralizedplasmacytomaoflymphnodesinalivertransplantrecipientduringtheconversionofimmunosuppressivetherapyfromtacrolimustoeverolimus
AT vrgorodetskiy completeregressionofgeneralizedplasmacytomaoflymphnodesinalivertransplantrecipientduringtheconversionofimmunosuppressivetherapyfromtacrolimustoeverolimus
AT aasalienko completeregressionofgeneralizedplasmacytomaoflymphnodesinalivertransplantrecipientduringtheconversionofimmunosuppressivetherapyfromtacrolimustoeverolimus
AT naprobatova completeregressionofgeneralizedplasmacytomaoflymphnodesinalivertransplantrecipientduringtheconversionofimmunosuppressivetherapyfromtacrolimustoeverolimus
AT nakupryshina completeregressionofgeneralizedplasmacytomaoflymphnodesinalivertransplantrecipientduringtheconversionofimmunosuppressivetherapyfromtacrolimustoeverolimus
AT msnovruzbekov completeregressionofgeneralizedplasmacytomaoflymphnodesinalivertransplantrecipientduringtheconversionofimmunosuppressivetherapyfromtacrolimustoeverolimus